Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serap Yucel

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Cancer Chemotherapy and Pharmacology|August 9, 2014
Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen studyZuleyha Akgun, Sezer Saglam, Serap Yucel, et al.
The Journal of International Medical Research|January 16, 2018
The role of PET and MRI in evaluating the feasibility of skin-sparing mastectomy following neoadjuvant therapyFatma Umit Malya, Huseyin Kadioglu, Huseyin Kazim Bektasoglu, et al.
World Journal of Gastrointestinal Oncology|January 30, 2018
Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II studyZeynep Gural, Sezer Saglam, Serap Yucel, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2016
Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen studyKezban Nur Pilancı, Sezer Saglam, Alper Okyar, et al.
Journal of Cancer Research and Clinical Oncology|September 6, 2014
Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational studyEsra Kaytan Saglam, Serap Yucel, Emre Balik, et al.
European Journal of Radiology|June 7, 2023
REliability of consensus-based segMentatIoN in raDiomic feature reproducibility (REMIND): A word of cautionBurak Kocak, Aytul Hande Yardimci, Mehmet Ali Nazli, et al.
The Clinical Respiratory Journal|August 5, 2020
Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric StudyBilgehan Sahin, Banu Atalar, Esra Kaytan Saglam, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Chemotherapy and Pharmacology|August 9, 2014
Neoadjuvant chronomodulated capecitabine with radiotherapy in rectal cancer: a phase II brunch regimen studyZuleyha Akgun, Sezer Saglam, Serap Yucel, et al.
The Journal of International Medical Research|January 16, 2018
The role of PET and MRI in evaluating the feasibility of skin-sparing mastectomy following neoadjuvant therapyFatma Umit Malya, Huseyin Kadioglu, Huseyin Kazim Bektasoglu, et al.
World Journal of Gastrointestinal Oncology|January 30, 2018
Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II studyZeynep Gural, Sezer Saglam, Serap Yucel, et al.
Cancer Chemotherapy and Pharmacology|June 9, 2016
Chronomodulated oxaliplatin plus Capecitabine (XELOX) as a first line chemotherapy in metastatic colorectal cancer: A Phase II Brunch regimen studyKezban Nur Pilancı, Sezer Saglam, Alper Okyar, et al.
Journal of Cancer Research and Clinical Oncology|September 6, 2014
Adjuvant chemoradiotherapy after D2 resection in gastric cancer: a single-center observational studyEsra Kaytan Saglam, Serap Yucel, Emre Balik, et al.
European Journal of Radiology|June 7, 2023
REliability of consensus-based segMentatIoN in raDiomic feature reproducibility (REMIND): A word of cautionBurak Kocak, Aytul Hande Yardimci, Mehmet Ali Nazli, et al.
The Clinical Respiratory Journal|August 5, 2020
Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric StudyBilgehan Sahin, Banu Atalar, Esra Kaytan Saglam, et al.
Pageof 2